verified SJR 1,142 · Q1 • database Scopus / SJR & Web of Science indexed

France · Elsevier Masson s.r.l.

workspace_premium Q1 — Medicine (miscellaneous) lock Subscription Unclaimed

European Journal of Medicinal Chemistry

European Journal of Medicinal Chemistry is a journal indexed in SJR in Medicine (miscellaneous) and Drug Discovery with an H index of 215. It has an SJR impact factor of 1,142 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,142.

European Journal of Medicinal Chemistry focuses its scope in these topics and keywords: evaluation, inhibitors, derivatives, activity, biological, potent, synthesis, derivativessynthesis, discovery, agents, ...

ISSN: 0223-5234

Editorial: Elsevier Masson s.r.l.

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD

schedule Datos CoP · solo campos en BD

SJR Impact Factor trending_up

1,142 Q1

H-index 215

Tasa de Aceptación pie_chart

20% Selectiva

Fuente Acceptance_Rate

Tiempo a publicación hourglass_top

NPD

Campo Sin dato

Coste de Publicación (APC) payments

NPD Subscription

Ruta Non-OA NPD

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

1,142

H-index

215

Docs (year)

900

Docs 3y

2513

Total refs

69731

Cites 3y

16199

Citable 3y

2509

Cites/Doc 2y

5.97

Ref/Doc

77.48

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Antifungal estrogen-like imidazoles. Synthesis and antifungal activities of thienyl and 1H-pyrrolyl derivatives of 1-aryl-2-(1H-imidazol-1-yl)ethane

The influence of the lipophilicity of 7-oxoacyl-l-alanyl-d-isoglutamines on their immunorestoration activity in vivo

Effect of lowered lipophilicity on the affinity of PCP analogues for the PCP receptor and the dopamine transporter

DNA-binding properties of pyrrolo[2,1-c][1,4]benzodiazepine N10-C11 amidines

Dihydropyridines bearing an imidazo[2,1-b]thiazole system

Dibenzo[1,6]naphthyridindiones as modified quinolone antibacterials

Design and synthesis of substituted compounds containing the 1,4-benzodioxin subunit. New potential calcium antagonists

D1 Agonist and/or D2 antagonist dopamine receptor properties of a series of ergoline derivatives: a structure-activity study

Competition between two metabolic pathways: oxidation and desulfuration in the thiobarbiturate series

Carbonic anhydrase inhibitors - Part 47: Quantum chemical quantitative structure-activity relationships for a group of sulfanilamide Schiff base inhibitors of carbonic anhydrase

beta1- and beta2-Adrenoceptor antagonist activity of a series of para-substituted N-isopropylphenoxypropanolamines

Benzofuran derivatives as ETA-selective, non-peptide endothelin antagonists

SHOW MORE ARTICLES

Anxiolytic activity of analogues of 4-benzylamino-2-methyl-7H-pyrrolo[2,3-d]pyrimidines

"Synthesis and beta-adrenoceptor agonist properties of (¬±)-1-(3',4'-dihydroxyphenoxy)-3-(3"",4""-dimethoxyphenyl) ethylamino-2-propanol hydrochloride, (¬±)-RO363.HCl, and the (2S)-(-)-isomer"

Anthraquinone intercalators as carrier molecules for second-generation platinum anticancer drugs

Adenosine receptors: synthesis, structure-activity relationships and biological activity of new 6-amino purine derivatives

a-Methoxy-O-(N-arylcarbamoyl)oximes: synthesis and pharmacological activities

A rational approach to the design of flavones as xanthine oxidase inhibitors

A QSAR study confirming the heterogeneity of the HEPT derivative series regarding their interaction with HIV reverse transcriptase

A model allowing the design of modified nucleosides as HIV-RT inhibitors

A CoMFA investigation of sigma receptor binding affinity: Reexamination of a spurious sigma ligand

6-Amino-2,4-lutidine carboxamides: a-aminoamide derivatives as systemic and topical inflammation inhibitors

5(10=>9)Abeo-ergoline derivatives: Synthesis, 5-HT1A-receptor affinity and selectivity

2-Oxo-2-(phen-2-ylpyrrol-2-yl)acetamides as potential anxiolytic agents: Synthesis and affinity at the central benzodiazepine receptor

FAQS

In Country of Papers you can find SJR impact factor and other metrics to help you decide on a Journal.